Abstract
Cardiovascular inhibitory effects induced by intrathecal (i.t.) administration of adenosine A1 receptor agonist and its modulation by γ-aminobutyric acid(B) (GABA(B)) receptor was suggested by our previous report. In this experiment, we examined the mediation of cardiovascular effects of GABA(B) receptor stimulation by adenosine A1 and A2 in the spinal cord. I.t. administration of GABA(B) receptor agonist, baclofen (30, 60 and 100 nmol) produced a dose dependent decrease of blood pressure and heart rate. Pretreatment with adenosine A1 receptor antagonist, 8-cyclopentyl-1,3-dimethylxanthine (50 nmol), attenuated the depressor and bradycardiac effects of baclofen (100 nmol), but not with adenosine A2 receptor antagonist, 3,7-dimethyl-1-propargylxanthine (25 nmol). These results suggest that GABA(B) receptors in the spinal cord play an inhibitory role in the central cardiovascular regulation and that the depressor and bradycardiac actions are mediated by adenosine A1 receptors. (C) 2000 Elsevier Science Ireland Ltd.
| Original language | English |
|---|---|
| Pages (from-to) | 153-157 |
| Number of pages | 5 |
| Journal | Neuroscience Letters |
| Volume | 296 |
| Issue number | 2-3 |
| DOIs | |
| State | Published - 22 Dec 2000 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- γ-Aminobutyric acid(B) receptor
- Adenosine A receptor
- Adenosine A receptor
- Blood pressure
- Heart rate
- Spinal cord
Fingerprint
Dive into the research topics of 'Mediation of the cardiovascular response to spinal γ-aminobutyric acid(B) receptor stimulation by adenosine A1 receptors in anesthetized rats'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver